Natera’s Signatera tumor DNA blood test

ABC News reports that a new cutting edge blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating tumor DNA in the bloodstream for certain types of cancers. "What makes the tumor DNA different is that it has certain mutations that actually lead to the uncontrolled cell growth that became the cancer," Solomon Moshkevich, the general manager of oncology […]